BMB Reports : eISSN 1976-670X

Cited by CrossRef (8)

  1. Rasa Islam, Aleta Pupovac, Vera Evtimov, Nicholas Boyd, Runzhe Shu, Richard Boyd, Alan Trounson. Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy. Cells 2021;10:1058
    https://doi.org/10.3390/cells10051058
  2. Ahmet ACAR. Integrative profiling of CEACAM1 in different malignancies with implications on the SARS-CoV-2 infection genes ACE2 and TMPRSS2. 2023;51:215
    https://doi.org/10.15671/hjbc.1232843
  3. Alaa M. Khalifa, Takashi Nakamura, Yusuke Sato, Hideyoshi Harashima. Vaccination with a combination of STING agonist-loaded lipid nanoparticles and CpG-ODNs protects against lung metastasis via the induction of CD11bhighCD27low memory-like NK cells. Exp Hematol Oncol 2024;13
    https://doi.org/10.1186/s40164-024-00502-w
  4. Alessandro Poggi, Maria Raffaella Zocchi. Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges. Molecular Therapy - Oncolytics 2022;24:26
    https://doi.org/10.1016/j.omto.2021.11.016
  5. Ashraf Abdullah Saad. Targeting cancer-associated glycans as a therapeutic strategy in leukemia. All Life 2022;15:378
    https://doi.org/10.1080/26895293.2022.2049901
  6. Nina Miazek-Zapala, Aleksander Slusarczyk, Aleksandra Kusowska, Piotr Zapala, Matylda Kubacz, Magdalena Winiarska, Malgorzata Bobrowicz. The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era. Cells 2021;10:1511
    https://doi.org/10.3390/cells10061511
  7. Nayoung Kim, Eunbi Yi, Eunbi Lee, Hyo Jin Park, Hun Sik Kim. Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression. Front. Immunol. 2024;15
    https://doi.org/10.3389/fimmu.2024.1388018
  8. Alaa M. Khalifa, Takashi Nakamura, Yusuke Sato, Takanori Sato, Mamoru Hyodo, Yoshihiro Hayakawa, Hideyoshi Harashima. Interval- and cycle-dependent combined effect of STING agonist loaded lipid nanoparticles and a PD-1 antibody. International Journal of Pharmaceutics 2022;624:122034
    https://doi.org/10.1016/j.ijpharm.2022.122034